250 related articles for article (PubMed ID: 23892229)
1. Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.
Shen H; Hyrc KL; Goldberg MP
Neurobiol Dis; 2013 Nov; 59():69-79. PubMed ID: 23892229
[TBL] [Abstract][Full Text] [Related]
2. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration.
Yahata N; Yuasa S; Araki T
J Neurosci; 2009 May; 29(19):6276-84. PubMed ID: 19439605
[TBL] [Abstract][Full Text] [Related]
4. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering.
Avery MA; Rooney TM; Pandya JD; Wishart TM; Gillingwater TH; Geddes JW; Sullivan PG; Freeman MR
Curr Biol; 2012 Apr; 22(7):596-600. PubMed ID: 22425157
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
Sasaki Y; Vohra BP; Lund FE; Milbrandt J
J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
[TBL] [Abstract][Full Text] [Related]
6. Identification of a critical site in Wld(s): essential for Nmnat enzyme activity and axon-protective function.
Jia H; Yan T; Feng Y; Zeng C; Shi X; Zhai Q
Neurosci Lett; 2007 Feb; 413(1):46-51. PubMed ID: 17207927
[TBL] [Abstract][Full Text] [Related]
7. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration.
Di Stefano M; Nascimento-Ferreira I; Orsomando G; Mori V; Gilley J; Brown R; Janeckova L; Vargas ME; Worrell LA; Loreto A; Tickle J; Patrick J; Webster JR; Marangoni M; Carpi FM; Pucciarelli S; Rossi F; Meng W; Sagasti A; Ribchester RR; Magni G; Coleman MP; Conforti L
Cell Death Differ; 2015 May; 22(5):731-42. PubMed ID: 25323584
[TBL] [Abstract][Full Text] [Related]
8. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
[TBL] [Abstract][Full Text] [Related]
9. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
10. Molecular chaperones protect against JNK- and Nmnat-regulated axon degeneration in Drosophila.
Rallis A; Lu B; Ng J
J Cell Sci; 2013 Feb; 126(Pt 3):838-49. PubMed ID: 23264732
[TBL] [Abstract][Full Text] [Related]
11. The cellular distribution of the Wld s chimeric protein and its constituent proteins in the CNS.
Fang C; Bernardes-Silva M; Coleman MP; Perry VH
Neuroscience; 2005; 135(4):1107-18. PubMed ID: 16154290
[TBL] [Abstract][Full Text] [Related]
12. Wld S requires Nmnat1 enzymatic activity and N16-VCP interactions to suppress Wallerian degeneration.
Avery MA; Sheehan AE; Kerr KS; Wang J; Freeman MR
J Cell Biol; 2009 Feb; 184(4):501-13. PubMed ID: 19237597
[TBL] [Abstract][Full Text] [Related]
13. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice.
Conforti L; Wilbrey A; Morreale G; Janeckova L; Beirowski B; Adalbert R; Mazzola F; Di Stefano M; Hartley R; Babetto E; Smith T; Gilley J; Billington RA; Genazzani AA; Ribchester RR; Magni G; Coleman M
J Cell Biol; 2009 Feb; 184(4):491-500. PubMed ID: 19237596
[TBL] [Abstract][Full Text] [Related]
14. A novel Drosophila model of nerve injury reveals an essential role of Nmnat in maintaining axonal integrity.
Fang Y; Soares L; Teng X; Geary M; Bonini NM
Curr Biol; 2012 Apr; 22(7):590-5. PubMed ID: 22425156
[TBL] [Abstract][Full Text] [Related]
15. Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
Beirowski B; Babetto E; Gilley J; Mazzola F; Conforti L; Janeckova L; Magni G; Ribchester RR; Coleman MP
J Neurosci; 2009 Jan; 29(3):653-68. PubMed ID: 19158292
[TBL] [Abstract][Full Text] [Related]
16. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
Babetto E; Beirowski B; Janeckova L; Brown R; Gilley J; Thomson D; Ribchester RR; Coleman MP
J Neurosci; 2010 Oct; 30(40):13291-304. PubMed ID: 20926655
[TBL] [Abstract][Full Text] [Related]
17. Axonal transport plays a crucial role in mediating the axon-protective effects of NmNAT.
Fang C; Decker H; Banker G
Neurobiol Dis; 2014 Aug; 68():78-90. PubMed ID: 24787896
[TBL] [Abstract][Full Text] [Related]
18. Wallerian degeneration, wld(s), and nmnat.
Coleman MP; Freeman MR
Annu Rev Neurosci; 2010; 33():245-67. PubMed ID: 20345246
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.
Gillingwater TH; Wishart TM; Chen PE; Haley JE; Robertson K; MacDonald SH; Middleton S; Wawrowski K; Shipston MJ; Melmed S; Wyllie DJ; Skehel PA; Coleman MP; Ribchester RR
Hum Mol Genet; 2006 Feb; 15(4):625-35. PubMed ID: 16403805
[TBL] [Abstract][Full Text] [Related]
20. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
Yan T; Feng Y; Zhai Q
Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
